1
Clinical Trials associated with Estradiol Valerate/Dienogest/Levomefolate calciumOpen-label, Randomized, Cross-over Study to Investigate the Bioequivalence of Estradiol Valerate (EV), Dienogest (DNG) and Levomefolate Calcium After Single Oral Administration of a Tablet Formulation Containing 2 mg Estradiol Valerate and 3 mg Dienogest Without and With 0.451 mg Levomefolate Calcium and a Tablet Formulation Containing 0.451 mg Levomefolate Calcium in 42 Healthy Postmenopausal Women
Investigation of the bioequivalence (BE) of Estradiol Valerate (EV) and Dienogest (DNG) after administration of one film-coated tablet containing 2 mg Estradiol Valerate, 3 mg Dienogest and 0.451 mg Levomefolate calcium as compared to one film-coated tablet containing 2 mg Estradiol Valerate,3 mg Dienogest.Investigation of the bioequivalence of levomefolate calcium after administration of one film-coated tablet containing 2 mg Estradiol Valerate, 3 mg Dienogest and 0.451 mg Levomefolate calcium as compared to one film-coated tablet containing 0.451 mg levomefolate calcium
100 Clinical Results associated with Estradiol Valerate/Dienogest/Levomefolate calcium
100 Translational Medicine associated with Estradiol Valerate/Dienogest/Levomefolate calcium
100 Patents (Medical) associated with Estradiol Valerate/Dienogest/Levomefolate calcium
100 Deals associated with Estradiol Valerate/Dienogest/Levomefolate calcium